Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma

Urological Research

Volumn 24, Issue 2, 1996, Pages 101-106

  Hobarth K ^a   Hallas, A ^a   Steiner, G ^a   Gomahr, A ^b   Aulitzky, W ^b   Marberger, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b St Johanns Spital   (Austria)

Author keywords

circulating immune markers; immunotherapy; interferon gamma; renal cell carcinoma

Indexed keywords

CD4 ANTIBODY; CD8 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIGENS, CD4; ANTIGENS, CD8; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; E-SELECTIN; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 0029879820     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00431087     Document Type: Article

References (39)

1. Aulitzky W, Gastl G, Aulitzky WE, Nachbaur K, Lanske B, Kemmler G, Flener R, Frick J, Huber C (1987) Interferon-γ for the treatment of metastatic renal cancer, dose-dependent stimulation and down regulation of beta 2 microglobulin and neopterin responses. Immunobiology 176:85
2. Ball ED, Guyre PM, Glynn JM, Rigby WFC, Fanger MW (1984) Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium re-induction by γ-IFN and 1,25-dihydroxyvitamin D3 (calcitriol). J Immunol 132:2424
3. Banner BF, Burnham JA, Bahnson RR, Ernstoff MS, Auerbach HE (1990) Immunophenotypic markers in renal cell carcinoma. Mod Pathol 3:129
4. Bichler KH, Kleinknecht S, Strohmaier WL (1990) Immune status and immune therapy of renal cell carcinoma. Urol Int 45:269
5. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245
6. Flyer DC, Burakoff SJ, Faller DV (1985) Retrovirus induced changes in major histocompatibility complex antigen expression influence suscepibility to lysis by cytotoxic T lymphocytes. J Immunol 135:2287
7. Grups JW, Frohmüller HGW (1990) Influence of cyclic interferon gamma and lymphocytes and their subpopulations in patients with renal carcinoma. Urology 35:111
8. Halloran PF, Jephthah-Ochola J, Urmson J, Farkas S (1985) Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney. J Immunol 135, 2:1053
9. Halloran PF, Wadgymar A, Autenried P (1986) The regulation of expression of major histocompatibility complex products. Transplantation 41:413
10. Hammerling GJ, Wallich R, Bulbuc N, Katzav S, Segal S, Feldman M (1985) Abrogation of metastatic properties of tumor cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 315:301
11. Harning R, Maninolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R (1991) Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 51:5003
12. Heicappell R, Ackermann R (1990) Rationale for immunotherapy of renal cell carcinoma. Urol Res 18:357
13. Hession C, Osborn L, Goff D, Chi-Rosso G, Vassallo C, Pasek M, Pittack C, Tizard R, Goetz S, McCarthy K, Hopple S, Lobb R (1990) Endothelial leukocyte adhesion molecule 1: direct expression cloning and functional interactions. Proc Natl Acad Sci USA 87:1673
14. Ho AD, Grossman M, Trümper L, Pezzutto A, Pralle H, Boedewadt-Radzun S, Papendick U, Göd B, Zwingers T, Hunstein W (1990) Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia. Blood 75:1119
15. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G (1989) De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis Proc Natl Acad Sci 86:641
16. Killander D, Lindhal P, Lundin L, Leary P, Gresser I (1976) Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L1210 cells and their position in the cell cycle. Eur J Immunol 6:56
17. Kyan-Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH (1991) Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 146:521
18. + effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci USA 79:4395
19. Minervini R, Panichi V, Vigano L, Felipetto R, Gattai V, Cecchi M, Fiorentini L, Palla R (1994) Cellular expression of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in normal kidney structures and in renal cancer. Eur Urol 26:103
20. Mukherji B, Ergin MT, Guha A, Tatake RT, Nashed AL (1986) Suppressor cell activities in autologous human tumor systems: suppression of tumor immunity. Arch Surg 121:1404
21. Munro JM, Pober JS, Cotran RS (1991) Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1. Lab Invest 64:295
22. 2-microglobulin release: II. In vivo studies with recombinant interferons and antigen. Immunobiol 177:66
23. Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S (1990) Differential expression of intercellular adhesion molecule 1 in primary and metastatic lesions. Cancer Res 50:1271
24. Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Remold HG, Welte K, Rubin BY, Murray HW (1984) Activation of human macrophages. Comparison of other cytokines with Interferon gamma. J Exp Med 160:600
25. Pfizenmaier K, Bartsch H, Scheurich P, Selinger B, Ucer U, Vehmeyer K, Nagel GA (1985) Differential γ-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of γ-interferon on tumor cell growth Cancer Res 45:3503
26. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893
27. Potocnik AJ, Kinne R, Menninger H, Zacher J, Emmerich F, Kroczek RA (1990) Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 31:213
28. Pui CH, Ip SH, Dodge RK, Carrabis S, Brown M, Crist WM, Berard CW, Kung P, Dahl GV, Murphy SB (1988) Serum-levels of CD8 antigen in childhood lymphoid malignancies, a possible indicator of increased suppressor cell activity in poor-risk patients. Blood 73:1015
29. Pui CH, Ip SH, Thompson E, Dodge RK, Brown M, Wiliams J, Carrabis S, Kung P, Berard CW, Crist WM (1989) Increased serum CD8 antigen level in childhood Hodgkins's disease relates to advanced stage and poor treatment outcome. Blood 73, 1:209
30. Reinherz EL, Schlossman SF (1980) The differentiation and function of human T lymphocytes. Cell 19:821
31. Von Roenn J, Harris JE, Braun DP (1987) Suppressor cell function in solid tumor cancer patients. J Clin Oncol 5:150
32. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ (1988) Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 141:1665
33. Tanaka K, Yoshioka T, Bieberich C, Jay G (1988) Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Ann Rev Immunol 6:359
34. Taniguchi K, Kaerre K, Klein G (1985) Lung colonization and metastasis by disseminated B 16 melanoma cells: H-2 associated control at the level of the host and tumor cell. Int J Cancer 36:503
35. Tomita Y, Nishiyama T, Fujiwara M, Sato S (1990) Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumor-infiltrating mononuclear cells in renal cell cancer. Br J Urol 62:354
36. Vanky F, Wang P, Patarroyo M, Klein E (1990) Expression of adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother 31:19
37. Vibe-Peterson J, Tvede N, Diamant M, Kjerulff AA, Sorensen HR (1991) Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer. Cancer Immunol Immunoter 33:121
38. Weiner LM, Steplewski Z, Koprowski H, Litwin S, Comis RL (1988) Divergent dose related effects of γ-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes. Cancer Res 48:1042
39. Zembala M, Mytar B, Popiela T, Asherson GL (1977) Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients' the role of suppressor cells. Int J Cancer 19:605